Medications
Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
08/17/2018
JERUSALEM & TARRYTOWN, N.Y.–(BUSINESS WIRE)–Aug. 16, 2018– Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive topline results from a Phase
Read More